Soewondo et al3 performed a multicenter, prospective study to evaluate the efficacy and safety of using biphasic insulin aspart 30 (BIAsp 30) during Ramadan as monotherapy, or in combination with an oral hypoglycaemic agent
, in persons with type 2 diabetes.
"The partnership will enhance access to this novel oral hypoglycaemic agent
by leveraging the huge marketing network of NeoBiocon and distribution network of NMC Healthcare.
As compared to most of the previous reports, our case study illustrates that even patients without a history of diabetes or oral hypoglycaemic agent
use, can manifest this life-threatening side-effect.
Madam, Metformin is a biguanide oral hypoglycaemic agent
approved as first line therapy for type 2 diabetes mellitus.
The present study has been undertaken to evaluate the effectiveness of Tinospora cordifolia as a hypoglycaemic agent
in normal and Streptozotocin-induced diabetic albino rats.
T2DM can be treated by different methods ranging from life style modifications to oral hypoglycaemic agents
and Insulin injections.
In Cwm Taf Health Board, the error rate for patients who were treated with oral hypoglycaemic agents
, to control their blood sugar levels, was 60% and the insulin error rate ranged from 23% at the Royal Glamorgan Hospital to 64% at Prince Charles Hospital.
Jamal said during five days of Hajj it is difficult to carry Insulin and if the patient is taking combination of Insulin and Oral hypoglycaemic agents
, the dose of Insulin can be omitted and dose of Oral agents can be increased.
Patients with Type 2 DM typically control their plasma glucose levels by diet and oral hypoglycaemic agents
. There are a number of different types of tablet available, which are summarised in Table 5 (for full details please refer to BNF or MIMS).
The 4-T study was designed to answer this question--it compared the initiation of insulin as additive therapy with oral hypoglycaemic agents
using a basal, biphasic or prandial regimen.
Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents
in patients with type 2 diabetes mellitus.